Resolution of C1q deposition but not of the clinical nephrotic syndrome after immunomodulating therapy in focal sclerosis
Background: The natural evolution of C1q nephropathy (C1qNP) during immunosuppressive treatment is relatively little studied or understood. Case Presentation: A 30 year-old Caucasian female was referred to us for further management of biopsy-proven C1qNP and severe nephrotic syndrome. Serologic work...
Main Authors: | Tibor Tibor Fülöp, Éva Csongrádi, Anna A. Lerant, Matthew Lewin, Jack R. Lewin |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2015-10-01
|
Series: | Journal of Nephropathology |
Subjects: | |
Online Access: | https://nephropathol.com/PDF/jnp-4-54.pdf |
Similar Items
-
Cyclophosphamide in the treatment of focal segmental glomerulosclerosis
by: R. Martinelli, et al.
Published: (2004-09-01) -
Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab
by: Karasavvidou Foteini, et al.
Published: (2011-07-01) -
Nephrotic syndrome due to focal segmental glomerulosclerosis complicating scleroderma: a case report
by: Mahsa Mehdipour Dalivand, et al.
Published: (2024-01-01) -
Successful treatment of a rare variant of mesangioproliferative glomerulonephritis with IgM deposits with Cyclosporin A
by: Daria V. Gurova, et al.
Published: (2020-07-01) -
Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis
by: Eujin Park, et al.
Published: (2020-06-01)